Drug Companies Will Be Fined

Health and Human Services’ Resources and Services Administration released a final rule that imposes fines on drug companies that overcharge hospitals and clinics for medication purchased under the government’s 340B drug discount program. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.